Literature DB >> 9144481

Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks antigen-mediated, but not CD3 monoclonal antibody-induced, activation of murine CD4+ T cells.

J Shi1, T Cinek, K E Truitt, J B Imboden.   

Abstract

Perturbation of several distinct T cell molecules, including the CD3/TCR complex, CD7, and CD28, activates phosphatidylinositol 3-kinase (PI3-K), but a clear consensus on the role of PI3-K in T cell activation has yet to emerge. We report here that CD3 mAb-induced IL-2 production by CD4+ T cells from DO11.10 TCR-alphabeta-transgenic mice is refractory to the potent PI3-K inhibitor, wortmannin, demonstrating that activation under these conditions is independent of PI3-K. In marked contrast, wortmannin substantially inhibits IL-2 production elicited by Ag (OVA(323-339) peptide) presented by appropriate APCs (syngeneic B7+ B cell blasts) and blocks Ag-induced differentiation of naive CD4+ DO11.10 T cells into IL-4-producing cells. Wortmannin inhibits Ag-induced conjugate formation between T cells and B7+ B cell blasts. Because T cell activation by Ag requires stable interactions with APCs, this inhibitory effect on conjugate formation may underlie the ability of wortmannin to block Ag-induced IL-2 production and differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144481

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.

Authors:  Alessandra Ghigo; Fulvio Morello; Alessia Perino; Federico Damilano; Emilio Hirsch
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 2.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

3.  Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores.

Authors:  Victoria A Martin; Wen-Horng Wang; Andrew M Lipchik; Laurie L Parker; Yantao He; Sheng Zhang; Zhong-Yin Zhang; Robert L Geahlen
Journal:  Cell Signal       Date:  2012-01-11       Impact factor: 4.315

4.  Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation.

Authors:  X Shan; M J Czar; S C Bunnell; P Liu; Y Liu; P L Schwartzberg; R L Wange
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.

Authors:  Jonathan A Deane; Michael G Kharas; Jean S Oak; Linda N Stiles; Ji Luo; Travis I Moore; Hong Ji; Christian Rommel; Lewis C Cantley; Thomas E Lane; David A Fruman
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

6.  The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells.

Authors:  Jean S Oak; Jing Chen; Raechel Q Peralta; Jonathan A Deane; David A Fruman
Journal:  Autoimmunity       Date:  2009-08       Impact factor: 2.815

7.  Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD).

Authors:  S Hirohata; T Hashimoto
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

8.  Overcoming Target Driven Fratricide for T Cell Therapy.

Authors:  Eytan Breman; Benjamin Demoulin; Sophie Agaugué; Sebastien Mauën; Alexandre Michaux; Lorraine Springuel; Julien Houssa; Fanny Huberty; Céline Jacques-Hespel; Céline Marchand; Jérôme Marijsse; Thuy Nguyen; Nancy Ramelot; Benjamin Violle; Dorothée Daro; Peter De Waele; David E Gilham; Valérie Steenwinckel
Journal:  Front Immunol       Date:  2018-12-12       Impact factor: 7.561

9.  B cell adaptor for PI3-kinase (BCAP) modulates CD8+ effector and memory T cell differentiation.

Authors:  Mark D Singh; Minjian Ni; Jenna M Sullivan; Jessica A Hamerman; Daniel J Campbell
Journal:  J Exp Med       Date:  2018-08-09       Impact factor: 14.307

10.  PI3Kδ promotes CD4(+) T-cell interactions with antigen-presenting cells by increasing LFA-1 binding to ICAM-1.

Authors:  Fabien Garçon; Klaus Okkenhaug
Journal:  Immunol Cell Biol       Date:  2016-01-07       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.